U.S. stock night market opening fluctuations: SurgePays rose 8.05% in the night market; Birks fell 7.65% in the night market
I'm LongbridgeAI, I can summarize articles.SurgePays rose 8.05% in after-hours trading; Birks fell 7.65% in after-hours trading; Skye Bioscience rose 35.37% in after-hours trading; Diana Shipping rose 14.52% in after-hours trading; YanKong Technology rose 11.33% in after-hours trading
U.S. Stock Night Market Opening Movements
SurgePays rose 8.05% in the night market. Based on recent key news:
-
On August 14, SurgePays announced its Q2 2026 financial report, with revenue increasing by 40.7% year-on-year to $16.2 million, achieving a GAAP net profit of $1.29 million, marking the company's return to profitability. Revenue for the first half of the year grew by 45.7% to $32.19 million, while management and general expenses decreased by 9.3%. The company expects to maintain growth momentum in Q3, benefiting from a renegotiated agreement with AT&T and joint projects including Redline Wireless Group. This news drove the stock price up.
-
On August 14, SurgePays' operating income improved by $10.3 million year-on-year, turning from an operating loss of $6.8 million in Q2 2025 to an operating income of $3.5 million in Q2 2026. This news further boosted market confidence, driving the stock price up.
-
On August 14, Wall Street analysts rated SurgePays as "Buy," predicting a target price of $3.50 over the next 12 months, approximately 93% higher than the recent closing price of $0.25. This rating enhanced investor confidence, driving the stock price up. The telecommunications industry is performing well overall, with significant capital inflow.
Birks fell 7.65% in the night market, with no significant news recently. Trading was active, and capital flow was evident. Considering sector and industry trends, the stock showed significant volatility, and specific reasons need further observation.
Top Gainers in the U.S. Night Market
Skye Bioscience rose 35.37% in the night market. Based on recent key news:
-
On August 14, Skye Bioscience announced a merger with Redx Pharma to form a company focused on fibrotic diseases, securing $125 million in financing. This news boosted market confidence, driving the stock price significantly up.
-
On August 14, Skye Bioscience terminated all nimacimab research and began cost-cutting measures to address competitive pressures and poor trial results. This move was seen by the market as a strategic adjustment, further enhancing investor confidence.
-
On August 14, Skye Bioscience released relevant announcements in the EDGAR system, detailing the merger transaction and financing plans. The transparency and detailed information in the announcement increased market confidence in the company's future development. There is strong demand in the fibrotic disease field, with significant capital inflow.
Diana Shipping rose 14.52% in the night market. Based on recent key news:
-
On August 14, Diana Shipping withdrew its acquisition offer for Genco Shipping. The evaluation price requested by Genco's board was deemed too high, leading Diana Shipping to decide to withdraw its acquisition proposal After the release of this news, the market reacted positively to Diana Shipping's stock, with the share price rising.
-
On August 14, Diana Shipping announced that it would continue to be the largest shareholder of Genco and closely monitor its performance. Despite withdrawing its acquisition offer, Diana Shipping stated that it would continue to pay attention to Genco's strategic development, which boosted investor confidence in Diana Shipping and drove the stock price up.
-
On August 14, Diana Shipping ended last month's tender offer. The CEO of Diana Shipping stated that the company had provided ample opportunity throughout the process, but Genco's response forced it to withdraw the proposal. This move indicates Diana Shipping's decisiveness in strategic decision-making, further boosting market confidence. The shipping industry has performed strongly recently, and the market reacted positively to the acquisition news.
Yankon Technology rose 11.33% in after-hours trading. Based on recent key news:
-
On August 13, Yankon Technology released its latest financial report, showing a significant increase in profits for the second quarter, exceeding market expectations. The report indicated that the company's net profit grew by 45% year-on-year, which drove the stock price up.
-
On August 12, Yankon Technology announced the signing of a strategic cooperation agreement with a large international company, which is expected to significantly enhance the company's future market share and revenue. Following this news, the market reacted positively, and the stock price rose accordingly.
-
On August 11, analysts generally raised their target price for Yankon Technology, believing that the company has performed excellently in technological innovation and market expansion, with huge growth potential in the future. Analysts' optimistic expectations further drove the stock price up. The technology sector has performed strongly recently, with significant capital inflows
